The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia

The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
复制标题

核因子-κ B 和细胞因子的相互作用与精神分裂症有关

DOI:
10.1016/j.biopsych.2008.10.018
复制
发表时间:
2009-03-15
影响因子:
10.6
通讯作者:
Zhao, Jing-Ping
Zhao, Jing-Ping
中科院分区:
医学1区
文献类型:
--
作者:
Song, Xue-Qin;Lv, Lu-Xian;Zhao, Jing-Ping

文献摘要

被引文献

相似文献

背景资料:许多研究表明精神分裂症与细胞因子介导的炎症反应有关,核因子-κ B(NF-κ B)调节细胞因子的表达。然而,目前还不清楚是否NF-κ B和细胞因子之间的相互作用是牵连在精神分裂症和精神抑制剂治疗4周的效果是否与cytokines.Methods的改变:65例健康受试者和83例首发精神分裂症患者谁符合DSM-IV标准,谁从来没有用精神抑制剂治疗以前被包括在内。采用夹心酶免疫法(EIA)检测血清细胞因子如白细胞介素-1 β(IL-1 β)和肿瘤坏死因子-α(TNF-α)水平。采用半定量逆转录聚合酶链反应(RT-PCR)检测外周血单个核细胞(PBMC)细胞因子(IL-1 β、TNF-α)和NF-κ B(B)mRNA的表达。结果:精神分裂症患者血清IL-1 β和TNF-α水平及PBMC mRNA表达水平均显著高于健康对照组。然而,用抗精神病药利培酮治疗4周可显著降低精神分裂症患者血清IL-1 β水平和PBMC mRNA表达。患者外周血NF-κ B B活性和PBMC mRNA表达水平均显著高于健康对照组。此外,精神分裂症患者和健康对照组PBMC中IL-1 β和TNF-α mRNA表达与NF-κ B B活化呈正相关。结论:精神分裂症患者存在细胞因子系统激活和免疫功能紊乱。NF-κ B活化可能通过与细胞因子相互作用在精神分裂症中发挥关键作用。
Background: Many reports suggest that schizophrenia is associated with the inflammatory response mediated by cytokines, and nuclear factor-kappa B (NF-kappa B) regulates the expression of cytokines. However, it remains unclear whether the interaction between NF-kappa B and cytokines is implicated in schizophrenia and whether the effect of neuroleptics treatment for 4 weeks is associated with the alteration of cytokines.Methods: Sixty-five healthy subjects and 83 first-episode schizophrenic patients who met DSM-IV criteria and who were never treated with neuroleptics previously were included. Serum levels of cytokines such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) were examined by using sandwich enzyme immunoassay (EIA). Peripheral blood mononuclear cell (PBMC) mRNA expressions of cytokines (IL-1 beta, TNF-alpha) and NF-kappa B were detected by using semiquantitative reverse transcription polymerase chain reaction (RT-PCR). NF-kappa B activation was examined by using transcription factor assay kits.Results: Schizophrenic patients showed significantly higher serum levels and PBMC mRNA expressions of IL-1 beta and TNF-alpha compared with healthy subjects. However, treatment with the neuroleptic risperidone for 4 weeks significantly decreased serum levels and PBMC mRNA expressions of IL-1 beta in schizophrenic patients. NF-kappa B activation and PBMC mRNA expression in patients were significantly higher than those in healthy subjects. Furthermore, PBMC mRNA expressions of IL-1 beta and TNF-alpha were positively correlated to NF-kappa B activation in both schizophrenic patients and healthy control subjects.Conclusions: Schizophrenic patients showed activation of the cytokine system and immune disturbance. NF-kappa B activation may play a pivotal role in schizophrenia through interaction with cytokines.